Published in J Allergy Clin Immunol on September 01, 2004
Airway hyperresponsiveness in asthma: mechanisms, clinical significance, and treatment. Front Physiol (2012) 0.87
Role of bronchoprovocation tests in identifying exercise-induced bronchoconstriction in a non-athletic population: a pilot study. J Thorac Dis (2017) 0.75
Absence of hyper-responsiveness to methacholine after specific bronchial provocation tests in a worker with hydroxyapatite-induced occupational asthma. Allergy Asthma Immunol Res (2011) 0.75
Mechanisms of airway hyperresponsiveness. J Allergy Clin Immunol (2006) 2.56
Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med (2014) 2.53
Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. Am J Respir Crit Care Med (2010) 2.31
The bronchoprotective effect of inhaling methacholine by using total lung capacity inspirations has a marked influence on the interpretation of the test result. J Allergy Clin Immunol (2006) 1.65
Importance of dosimeter calibration method on nebulizer output. Ann Allergy Asthma Immunol (2005) 1.41
Nonspecific interstitial pneumonia and usual interstitial pneumonia with mutation in surfactant protein C in familial pulmonary fibrosis. Mod Pathol (2004) 1.37
Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthma. J Allergy Clin Immunol (2009) 1.23
The use of noninvasive ventilation in acute respiratory failure at a tertiary care center. Chest (2004) 1.23
Examining asthma quality of care using a population-based approach. CMAJ (2008) 1.17
The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma. J Allergy Clin Immunol (2003) 1.13
Prolonged survival in Churg-Strauss syndrome. Ann Allergy Asthma Immunol (2004) 1.07
Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses. Am J Respir Crit Care Med (2008) 1.05
Difference between dosimeter and tidal breathing methacholine challenge: contributions of dose and deep inspiration bronchoprotection. Chest (2005) 1.02
Differences in respiratory symptoms and pulmonary function in children in 2 Saskatchewan communities. Ann Allergy Asthma Immunol (2004) 0.92
Respiratory symptoms and lung function in poultry confinement workers in Western Canada. Can Respir J (2003) 0.92
Regional variations in risk factors for asthma in school children. Can Respir J (2005) 0.91
Methacholine challenge: comparison of two methods. Chest (2005) 0.90
Lung function and farm size predict healthy worker effect in swine farmers. Chest (2007) 0.88
Levalbuterol has not been established to have therapeutic advantage over racemic albuterol. J Allergy Clin Immunol (2002) 0.87
Effects of MMP-9 inhibition by doxycycline on proteome of lungs in high tidal volume mechanical ventilation-induced acute lung injury. Proteome Sci (2010) 0.86
ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels. J Immunol (2009) 0.86
Hypersensitivity pneumonitis as a cause of airway-centered interstitial fibrosis. Ann Allergy Asthma Immunol (2007) 0.84
Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate. Ann Allergy Asthma Immunol (2004) 0.83
Familial interstitial pulmonary fibrosis: a large family with atypical clinical features. Can Respir J (2010) 0.82
Nebulizer output for methacholine challenges with the KoKo Digidoser. J Allergy Clin Immunol (2005) 0.81
Nitrofurantoin-associated bronchiolitis obliterans organizing pneumonia: report of a case. Can Respir J (2008) 0.81
Normal expiratory flow rate and lung volumes in patients with combined emphysema and interstitial lung disease: a case series and literature review. Can Respir J (2011) 0.81
Sex differences in asthma, atopy, and airway hyperresponsiveness in a university population. Ann Allergy Asthma Immunol (2003) 0.81
Correlation between airway inflammation and loss of deep-inhalation bronchoprotection in asthma. Ann Allergy Asthma Immunol (2008) 0.80
The American Thoracic Society's spirometric criteria alone is inadequate in asthma diagnosis. Can Respir J (2006) 0.80
Past, present and future uses of methacholine testing. Expert Rev Respir Med (2012) 0.80
Factors contributing to risks for pediatric asthma in rural Saskatchewan. Ann Allergy Asthma Immunol (2012) 0.80
Diagnostic and therapeutic value of airway challenges in asthma. Curr Allergy Asthma Rep (2009) 0.79
Methacholine challenge methods. Chest (2008) 0.78
Occurrence of new-onset wheeze in a 3-year follow-up study of schoolchildren. Ann Allergy Asthma Immunol (2007) 0.78
Seasonal fluctuations in airway responsiveness in elite endurance athletes. Can Respir J (2004) 0.77
Refractoriness to inhaled mannitol 3 hours after allergen challenge. Ann Allergy Asthma Immunol (2013) 0.77
Effect of combined montelukast and desloratadine on the early asthmatic response to inhaled allergen. J Allergy Clin Immunol (2005) 0.77
Salbutamol tolerance to bronchoprotection: course of onset. Ann Allergy Asthma Immunol (2012) 0.77
Effect of a single dose of montelukast sodium on methacholine chloride PC20. Can Respir J (2005) 0.76
Duration of bronchoprotection of inhaled ipratropium against inhaled methacholine. Ann Allergy Asthma Immunol (2009) 0.76
A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responses. Am J Respir Crit Care Med (2015) 0.76
Role of leukotriene receptor antagonists in the treatment of exercise-induced bronchoconstriction: a review. Allergy Asthma Clin Immunol (2005) 0.76
Effects of ASM-024, a modulator of acetylcholine receptor function, on airway responsiveness and allergen-induced responses in patients with mild asthma. Can Respir J (2015) 0.75
Allergen-induced asthma. Can Respir J (2014) 0.75
Respiratory medicine in Saskatchewan: An historical perspective. Can Respir J (2015) 0.75
A posterior pneumothorax. Can Respir J (2013) 0.75
Deep inhalation bronchodilation and oral corticosteroids in asthma. Chest (2006) 0.75
Acute interstitial pulmonary edema. Can Respir J (2014) 0.75
Excess longitudinal decline in lung function in grain farmers. J Agromedicine (2010) 0.75
Methacholine test and the diagnosis of asthma. J Allergy Clin Immunol (2012) 0.75
Method of nebulizer calibration and methacholine airway responsiveness. J Allergy Clin Immunol (2004) 0.75
Methacholine PC20: 1-point formula. Ann Allergy Asthma Immunol (2007) 0.75
Asbestosis and probable microscopic polyangiitis. Can Respir J (2004) 0.75
Comparison of doubling and quadrupling methacholine concentration regimens using the tidal volume method. Ann Allergy Asthma Immunol (2011) 0.75
Formoterol thrice weekly does not result in the development of tolerance to bronchoprotection. Can Respir J (2003) 0.75
Metastatic pulmonary urothelial carcinoma of the renal pelvis with an unusual presentation. Acta Cytol (2004) 0.75
The effect of caffeinated coffee on airway response to methacholine and exhaled nitric oxide. Respir Med (2011) 0.75
Histamine and methacholine challenge cut points. Ann Allergy Asthma Immunol (2010) 0.75
The effect of ipratropium nasal spray on bronchial methacholine challenge. Chest (2005) 0.75
Extrapolation of allergen PC15. Ann Allergy Asthma Immunol (2008) 0.75
Deep inhalation bronchoprotection. Ann Allergy Asthma Immunol (2012) 0.75
A case report of wegener granulomatosis treated only with corticosteroids for 30 years. Ann Allergy Asthma Immunol (2003) 0.75
Characterization of the methacholine PC15. Ann Allergy Asthma Immunol (2011) 0.75
A comparison of 2 methods of continuous aerosol administration during methacholine challenge testing. Respir Care (2006) 0.75
Lack of tachyphylaxis to methacholine at 24 h. Chest (2005) 0.75
Development of a methacholine challenge method to minimize methacholine waste. Chest (2003) 0.75
Microscopic pulmonary tumour embolism: an unusual presentation of thymic carcinoma. Can Respir J (2002) 0.75
Magnitude of bronchoprotection of albuterol vs methacholine: relationship to baseline airway caliber. Chest (2006) 0.75
Extrapolation of methacholine PC(20). Chest (2002) 0.75
Allergen challenge dose-response slope. J Allergy Clin Immunol (2008) 0.75
Deep inhalation bronchoprotection in asthma: correlation with airway responsiveness. J Allergy Clin Immunol (2006) 0.75
Exercise-induced hyperventilation: more common than appreciated. Ann Allergy Asthma Immunol (2012) 0.75
Deep inspiration avoidance and methacholine response in normal subjects and patients with asthma. Chest (2005) 0.75